Alimera Sciences Inc patents expiration

1. Iluvien patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8871241 ALIMERA SCIENCES INC Injectable sustained release delivery devices
Aug, 2027

(3 years from now)

Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient

Market Authorisation Date: 26 September, 2014

Treatment: NA


More Information on Dosage

ILUVIEN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic